Engineering / R&D White Papers

Creating Breakthrough Innovation During a Pharmaceutical Merger or Acquistion

Overview With industry challenges climbing, pharmaceutical companies are finding it difficult to sustain desired or expected revenue growth rates. Although Mergers and Acquisitions (M&A) offer several avenues for achieving growth, results are often short-lived. To develop capabilities that fuel growth over the long term, pharmaceutical firms should exploit M&A transactions as a potential way to dramatically improve Research and Development (R&D) productivity.

Further White Paper Details
PublisherIBM File FormatPDF, requires Acrobat Rdr 5
Date PublishedJuly 2002 Downloads462
FormatWhite Papers   
Topics

Quick Sitemap Links: